VitaNova Life Sciences (VNOV) Operating Income (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Operating Income came in at -$109860.0 in Q2 2026, down 110.15% YoY from $1.1 million in Q2 2025, and down 335.09% on a QoQ basis from $46731.0 in Q1 2026.
VitaNova Life Sciences (VNOV) Operating Income (2017 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 10 years of Operating Income data on file, last reported at -$109860.0 in Q2 2026.
- Quarterly Operating Income fell 110.15% year-over-year to -$109860.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $3601.0 (down 99.7% YoY) and the FY2026 annual result came in at $3601.0, down 99.7% from the prior year.
- Operating Income retreated to -$109860.0 in Q2 2026, from $46731.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of $1.1 million in Q2 2025 to a low of -$109860.0 in Q2 2026.
- A 5-year average of $109206.0 and a median of $5948.0 in 2024 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2023 — Operating Income slumped 1236.22% — and 2025, when it jumped 1730.43%.
- Tracing VNOV's Operating Income over 5 years: stood at $2134.0 in 2022, then plunged by 510.26% to -$8755.0 in 2023, then soared by 815.02% to $62600.0 in 2024, then jumped by 58.42% to $99170.0 in 2025, then sank by 210.78% to -$109860.0 in 2026.
- The last three Operating Income figures came in at -$109860.0 (Q2 2026), $46731.0 (Q1 2026), and $99170.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 1.32 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 1.12 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 729.00 Mn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 171.00 Mn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -8.03 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -35.15 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -2.90 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -2.93 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -109,860.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -109,860.00 |
| Jan 31, 2026 | 46,731.00 |
| Oct 31, 2025 | 99,170.00 |
| Jul 31, 2025 | -32,440.00 |
| Apr 30, 2025 | 1.08 Mn |
| Jan 31, 2025 | 108,874.00 |
| Oct 31, 2024 | 62,600.00 |
| Jul 31, 2024 | -45,414.00 |
| Apr 30, 2024 | 232,683.00 |
| Jan 31, 2024 | 5,948.00 |
| Oct 31, 2023 | -8,755.00 |
| Jul 31, 2023 | -24,247.00 |
| Jul 31, 2022 | 2,134.00 |
| Oct 31, 2021 | -29,991.00 |
| Jul 31, 2021 | -10,486.00 |
| Apr 30, 2021 | -25,563.00 |
| Jan 31, 2021 | -2,899.00 |
| Oct 31, 2020 | -12,385.00 |
| Jul 31, 2020 | -11,247.00 |
| Apr 30, 2020 | -26,337.00 |